NEXTBio Capital Management’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
NEXTBio Capital Management's BLSM Position: Q3 2026 in Review
NEXTBio Capital Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 250,000 shares worth $4.66M. The stake represents 1.99% of the portfolio and ranks #20 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- NEXTBio Capital Management held 250,000 shares of BlossomHill Therapeutics worth $4.66M as of Q3 2026.
- BlossomHill Therapeutics was a new NEXTBio Capital Management position in Q3 2026.
- BlossomHill Therapeutics made up 1.99% of NEXTBio Capital Management's portfolio in Q3 2026, its #20 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on NEXTBio Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.